We provide products and services for improved fish and animal health
VESO is a leading player in fish health and veterinary medicine. We have a strong foundation in research and innovation, offering solutions and products that promote animal health, infection control and sustainable production.
Contact usOur story
Establishment of VESO
VESO (Veterinærmedisinsk Oppdragssenter AS) was founded in 1988 by the Norwegian Agricultural Science Council. In 1991, it underwent a transformation into a limited company under the jurisdiction of the Ministry of Agriculture and Food.
Privatization of the company
From 2008 to 2010, VESO underwent a privatisation process through a Management Buy Out. In 2019, the government divested its entire stake, resulting in AquaNova Invest AS’s current ownership position in VESO. The remaining shares are held by present and former employees. Since the privatisation, VESO has experienced remarkable growth, with more than eightfold increased turnover. The substantial increase represents an average annual growth rate of >14%. VESO’s success can be attributed to several factors, including heightened market penetration, expansion within the fish and animal health sectors in Norway, strategic investments in new ventures, novel markets entries, and the introduction of innovative products and services.
Collaboration in Chile
In 2007, VESO embarked on a collaborative endeavour with Akvaforsk (currently known as NOFIMA) and Sintef in Chile. VESO assumed full ownership of the company in 2017. VESO Chile has since then demonstrated robust growth and currently holds a prominent position as a primary supplier to the fish farming industry in Chile.
Investment in Breeding and Genetics
Between 2007 and 2015, VESO allocated substantial resources towards the development of a breeding and genetics enterprise. Recognising the need for continued growth and expansion, VESO made a strategic decision to divest this business to Benchmark Holding in 2015.
Brynsløkken and antifouling
In 2016, VESO acquired a controlling interest (51%) in Brynsløkken AS, a company engaged in the development and manufacturing of antifouling and other chemical products. Since the acquisition, the company has exhibited substantial growth and advancement, establishing a prominent position as one of the leading suppliers in the industry.
VESO enters the Icelandic aquaculture market
In 2022, we established VESO EHF in Iceland in collaboration with an experienced Icelandic founding team. The company is positioned to capture its share of the anticipated growth within the Icelandic aquaculture market.
Expansion and diversification of the product portfolio
In recent years, the organisation has expanded within the domains of animal and fish health. In addition to pharmaceuticals, we have successfully broadened our offerings through strategic collaborations with pioneering and renowned international manufacturers. We have introduced a range of new products, including hygiene solutions, veterinary consumables, dietary supplements, and microbial products.
Regulatory consulting for aquaculture
In 2024 we expanded our services and offer regulatory consulting for development and registration of products for the global aquaculture market. By doing this we represent a provider of a complete service from the initial proof-of-concept trials to a registered product with market authorization.
Would you like to work with us?
At VESO we are passionate about fish- and animal health. Join us to have an opportunity to make a difference!
Contact us
